This study assessed the safety of sevoflurane anaesthesia using two Komesaroff vaporizers inside the circle with both spontaneous and controlled ventilation. Sevoflurane concentrations were continuously monitored using a mass spectrometer and the anaesthetic depth was easily controlled. Involuntary movements occurred in eight patients and breathholding occurred in five patients after inhalational induction. With continuous monitoring of sevoflurane concentrations, induction and maintenance of anaesthesia using a vaporizer inside the circle is safe during both controlled and spontaneous ventilation. However the high incidence of involuntary movements may limit the feasibility of induction in spontaneously breathing patients.
A major concern with anaesthesia using vaporizers inside the circle (VIC) is the potential for very high anaesthetic concentrations to build up inside the system. This results in excessive anaesthetic depth and is a particular risk with controlled ventilation. Continuous monitoring of anaesthetic concentrations is now common and can improve the safety of VIC anaesthesia. Sevoflurane is increasingly used for both the induction and maintenance of anaesthesia. Hence, we studied sevoflurane VIC anaesthesia with Komesaroff vaporizers (Medical Developments Australia, Springvale, Vic.) during both controlled and spontaneous ventilation with continuous monitoring of inspired and expired sevoflurane concentrations. We chose the Komesaroff vaporizer as it has a very low resistance to flow with a pressure drop of less than 0.2 mm water at 30 l.min -1 flow at both "on" and "off" settings 1 . It is a variable bypass, non-agentspecific vaporizer and is similar to the Goldman vaporizer. The Komesaroff vaporizer can be used in VIC and vaporizer outside circle (VOC) modes, and has five click settings: "off", "on" and three inter-mediate settings. The glass bowl is calibrated to 30 ml in 2 ml steps diagonally around the bowl 1 .
METHOD
After obtaining approval from the hospital ethics committee and consent from the patients, we anaesthetized 60 ASA 1 or 2 patients having elective surgery. Thirty patients in Group 1 had controlled ventilation and 30 patients in Group 2 breathed spontaneously during anaesthesia. Patients with severe cardiovascular, respiratory and psychiatric illnesses were excluded. Patients on treatment with sedative drugs were also excluded. All patients received oral midazolam 7.5 mg premedication one hour before induction of anaesthesia.
We placed two Komesaroff vaporizers in series immediately downstream of the inspiratory circle connection and inspiratory valve on the Dräger Narkomed 4 anaesthetic circle system (Dräger). The inspired (F SI ) and expired (F SE ) concentrations of sevoflurane, oxygen and carbon dioxide were monitored continuously with a Marquette M250 Random Access Mass Spectrometer (Marquette Medical Systems, Milwauke, Wisconsin, U.S.A.). Sampled gas was returned to the expiratory limb after analysis. Heat and moisture exchangers were placed on the patient end of the circle and microbial filters were placed on the expiratory limb.
Using a flow of 1 l.min -1 of oxygen, the patient was instructed to breathe normally for two minutes. The patients were informed beforehand that the facemask would be firmly placed to achieve a gas-tight seal and preoxygenation. The vaporizers were then set fully "on" for inhalational induction. Verbal contact was maintained with the patient and when this was lost, the eyelash reflex was checked at five-second intervals. We noted the time to loss of eyelash reflex, the number of breaths taken and F SE at this point. After the loss of the eyelash reflex, the Komesaroff vaporizers were kept fully on. In Group 1 atracurium 0.5 mg.kg -1 was administered after checking that "bag-mask ventilation" was possible. Fentanyl 2 µg.kg -1 was also administered in patients in whom endotracheal intubation was planned. A laryngeal mask (LMA) or endotracheal tube (ETT) was inserted three minutes after the administration of atracurium. The patients were ventilated with tidal volumes of 10 ml.kg -1 at 10 breaths.min -1 .
In Group 2, we checked that the patients' eyes were central and the F SE at least 3% before inserting a LMA. The patients breathed spontaneously and ventilation was only assisted if severe respiratory depression occurred after opioid administration.
In both groups, the time to LMA or ETT insertion and the F SE at those times were noted. Pulse rate, blood pressure, respiratory rate and end-tidal carbon dioxide concentrations were noted at one-minute intervals during the first 10 minutes of anaesthesia and then at three-minute intervals. The F SI and F SE were recorded every minute throughout anaesthesia. The presence of problems during induction, such as movements, breathholding, apnoea, coughing and laryngospasm was noted.
In both groups, after insertion of the LMA or ETT, the vaporizer settings were adjusted to maintain the F SE at 2.4 to 2.9% and further adjusted according to the patients' responses to surgery. Fentanyl and morphine were used for analgesia. Oxygen and air flowmeters were adjusted to maintain the inspired oxygen concentration at 30% with a total fresh gas flow of 1 l.min -1 throughout anaesthesia.
Towards the end of anaesthesia, the vaporizers were turned off and the LMAs and ETTs were removed. The duration of anaesthesia and the amount of liquid sevoflurane that had been used were noted using the volume scale on the vaporizer glass bowls.
RESULTS
The anaesthetic data of both Group 1 and Group 2 patients are listed in Table 1 . The times to loss of eyelash reflex were similar, 97.8 after 18.1 breaths at a mean F SE of 2.0% in Group 1 and 95.5 after 18.8 breaths at a mean F SE of 2.2% in Group 2. The F SI and F SE during induction for Group 1 are shown in Figure 1 and for Group 2 in Figure 2 .
The times to successful LMA or ETT insertion are also in Table 1 . The LMAs were removed and reinserted after deepening anaesthesia in seven (23.3%) Group 2 patients who reacted to LMA insertion. Involuntary movements and muscle rigidity occurred in eight (26.7%) Group 2 patients after the loss of the eyelash reflex. These movements persisted even as anaesthesia deepened and the F SE exceeded 3%, for up to three minutes. In two patients, these movements were very severe and propofol was administered to enable anaesthesia to continue. Transient breathholding also occurred in five (16.7%) Group 2 patients after loss of the eyelash reflex. In all five patients, spontaneous ventilation resumed within one minute after briefly assisting ventilation. While cardiovascular depression occurred, no patient had a mean arterial pressure of less than 55 mmHg or a heart rate of less than 50 beats.min -1 during induction.
During maintenance of anaesthesia, the F SE tended to remain steady at each setting used in both groups. The maximum F SI and F SE in Group 1 were 4.5% (0.6%) and 3.2% (0.4%) respectively. The maximum F SI and F SE in Group 2 were 5.0% (0.7%) and 3.6% (0.3%) respectively. The F SE tended to gradually decrease with time, necessitating higher settings of the vaporizers.
DISCUSSION
A major concern with VIC anaesthesia is the potential for high anaesthetic concentrations to build up inside the circle. This causes excessive anaesthetic depth, and cardiovascular and respiratory depression, especially during controlled ventilation. A major determinant of anaesthetic uptake and depth during VIC anaesthesia is the minute ventilation 2 . In spontaneously breathing patients, increases in anaesthetic depth depress ventilation, limiting uptake and further increases in anaesthetic depth. This safety factor is lost during controlled ventilation. Particularly as its blood gas solubility is very low, sevoflurane concentrations and anaesthetic depth may increase very rapidly.
With continuous monitoring of the F SE , excessive anaesthesia was not a problem during controlled or spontaneous ventilation in any patient. We found it easy to adjust and maintain the F SE within safe limits and according to surgical stimuli and cardiovascular state. A fast reduction in F SE could have been achieved by turning off the vaporizers and increasing the fresh gas flow, but this was not required in any patient. Rather, we found the F SI and F SE to be steady when the volume of liquid sevoflurane in the vaporizer was between 15 to 30ml. As the Komesaroff vaporizers were not temperature compensated, the sevoflurane cooled with progressive vaporization. There was a gradual decrease in the F SE over time and higher settings were needed when the residual volume of liquid sevoflurane was less than 15 ml. The limited vaporization capability of the Komesaroff vaporizers may in fact enhance its safety in sevoflurane VIC anaesthesia. Using two vaporizers and a fresh gas flow of 1 l.min -1 , there was a good range of safe vaporizer settings that could be used to good clinical effect.
Other studies have reported the safety of VIC anaesthesia using the Komesaroff vaporizer and controlled ventilation, Wright et al 3 used isoflurane at fresh gas flows of 1, 2 and 3 l.min -1 while Bewley et al 4 used halothane and isoflurane in a closed circuit. Another study using the Oxford Miniature Vaporizer in spontaneously breathing patients also found sevoflurane VIC anaesthesia to be feasible and safe 5 . That sevoflurane is less potent than halothane and isoflurane may contribute to its safety in VIC anaesthesia.
The induction times were slower than some studies using sevoflurane VOC and high fresh gas flow. Thwaites 6 reported an induction time of 84 s and Yurino 7 reported 52 s. However, they compare favorably with reported times by Fredman 8 of 153s and by Smith 9 of 109 s. No premedication was used in these VOC studies and Fredman's patients received fentanyl three minutes prior to induction 8 . We did not find a significant correlation between the weight of the patient and time to loss of eyelash reflex nor with the number of breaths taken to this time in both groups.
There is increasing evidence that sevoflurane can be used safely at low flows. Kharasch 10 and Bito 11 both found no difference between the effects of sevoflurane and isoflurane on renal function with a fresh gas flow of 1 l.min -1 . Using an even lower fresh gas flow may accelerate induction but will limit the range of safe settings that can be used during maintenance of anaesthesia. It may also be difficult to maintain adequate gas volume in the circle system during induction due to gas leakage when using facemasks. Further study is needed on methods to accelerate VIC induction such as using three Komesaroff vaporizers in series, or vital capacity breaths. Slow induction may have advantages. Sudden "loss of the airway", laryngospasm and coughing did not occur in any patient during induction. Breathholding appeared to be distinct from opiate-induced respiratory depression as spontaneous respiration resumed after a few assisted breaths.
The commonest problem was involuntary movements during induction, all in Group 2 patients. All occurred only after loss of eyelash reflexes and persisted even when the F SE reached 3.5%. The incidence of movements was more frequent than in a VOC study where the rise in sevoflurane concentration was faster 12 , but was lower than that in another VIC study 5 . The high incidence seems to be related to the slow rise in sevoflurane concentrations during SEVOFLURANE VIC ANAESTHESIA Anaesthesia and Intensive Care, Vol. 28, No. 1, February 2000 VIC induction. No patients recalled or were distressed by these movements. However, these movements may limit the feasibility of sevoflurane VIC induction when spontaneous ventilation is planned.
The safety of low-flow VOC anaesthesia also depends more on monitoring anaesthetic concentrations that the patient breathes rather than accuracy of vaporizer output. Many anaesthetic machines have integral agent analyzers that can facilitate both VOC and VIC low flow anaesthesia. It may be possible to use non-agent-specific VIC vaporizers when more costly calibrated sevoflurane specific VOC plenum vaporizers are unavailable.
In Bewley's study, 6.29 ml of liquid isoflurane produced end-tidal concentrations of 1.0 to 1.3% in one hour of closed circuit anaesthesia 4 . Our hourly liquid sevoflurane usage of 16.2 ml in Group 1 and 16.8 ml in Group 2 seems appropriate, as sevoflurane is only about half as potent as isoflurane, we induced anaesthesia with sevoflurane and used a higher fresh gas flow of 1 l.min -1 . The amount of liquid sevoflurane used would produce approximately 50 ml of vapour per minute. This is equivalent to the vapour output from a plenum VOC vaporizer set at 5% at the same fresh gas flow. The savings with closed circuit VIC sevoflurane should be measured once the safety of sevoflurane anaesthesia at basal flows has been established.
In conclusion, induction and maintenance of sevoflurane VIC anaesthesia using the Komesaroff vaporizer is simple and safe during both controlled and spontaneous ventilation provided that sevoflurane concentrations are continuously monitored.
